Members
Events
The Princess Máxima Center in Utrecht hosts the national CAR-T Symposium, an afternoon meeting on the latest developments in CAR-T cell therapy covering both translational research and clinical results.
A PhD-level course on how health economics and health technology assessment shape patient access to advanced therapies in Sweden. Mainly distance-based, with a campus day in Gothenburg on 20 November.
Keynotes and a panel on how connected labs, robotics and AI-ready data can help cell therapy manufacturing scale. A half-day event in Hellerup near Copenhagen, open to both in-person and online attendance.
How cell fate decisions are governed, and how that knowledge can be used to engineer human cells. Hsiu-Chuan Lin of the Centre for Genomic Regulation in Barcelona gives a guest lecture at Lund Stem Cell Center.
News
A lipid nanoparticle that turns circulating monocytes into CAR-macrophages, pointed at the T cells driving autoimmune disease rather than the B cells in vivo CAR work has targeted so far. Strike Pharma has filed on STR-2 and named four candidate indications.
Vinnova is backing joint life science projects with up to 3 million SEK apiece, the first money out of a government programme that also funds CCRM Nordic. Applications need three independent parties, including a company and a university, and close on 9 February 2027.
Vetenskapsrådet has put SEK 4 million behind a four-year attempt to settle how much baseline activity a CAR-T receptor needs in order to penetrate a solid tumour. The project is led by Elicera Therapeutics co-founder Di Yu at Uppsala University.
Bioprocess development at Testa Center in Uppsala is now part-funded again: up to five weeks of access per project, with 70 percent of the access fee covered for academic projects and 50 percent for companies. Weeks are allocated first come, first served and must be used by 30 April 2027.
A pre-GMP laboratory in Western Sweden will let ATMP developers prove out their manufacturing processes before committing to a GMP facility. It is one of two resources in Precisionsplattformen, backed by SEK 25 million in EU regional development and Västra Götalandsregionen funding.
The Royal Swedish Academy of Engineering Sciences has set out what Sweden needs to change to hold its position in advanced therapies. The IVA ATMP report asks for three national super-ecosystems, a transferable fast-track voucher at EU level and clearer national guidance on the hospital exemption.
Learn more about the Health Technology Assessment related issues of your ATMP development.
Support in navigating ATMP development needs prompting the right competence, need, and time.
Find or advertise ATMP relevant job opportunities.
The ATMP Sweden newsletter provides updates on Swedish ATMP- and association developments.